<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00393848</url>
  </required_header>
  <id_info>
    <org_study_id>R01AR052293</org_study_id>
    <secondary_id>70451</secondary_id>
    <secondary_id>1R01AR052293-01A2</secondary_id>
    <nct_id>NCT00393848</nct_id>
  </id_info>
  <brief_title>Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery</brief_title>
  <official_title>Restoration of Muscle Following Hip Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of two postoperative interventions
      designed to preserve muscle protein after major hip or knee surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hip fractures among the elderly are a major health concern. Nearly one-third of elderly hip
      fracture patients die within 1 year of the injury. Events surrounding the actual injury and
      any necessary surgical repair often lead to reduced muscle protein, and eventually, muscle
      strength. Loss in everyday function and independence may follow, especially in elderly or
      frail individuals. The decrease in protein synthesis may be caused by two main events
      following injury and surgery: prolonged inactivity and an increase in stress hormone levels.
      Preventing a loss in protein may help to improve outcomes for individuals undergoing hip
      surgery and rehabilitation. The purpose of this study is to determine the effects of two
      postoperative interventions designed to retain muscle protein after major hip or knee surgery
      in adults.

      This study will include two experiments. Experiment 1 will include individuals who are
      scheduled for hip or knee replacement surgery because of osteoarthritis (the need to repair
      or replace the affected joint), or avascular necrosis (bone tissue death caused by lack of
      blood supply). Experiment 1 participants will be randomly assigned to one of two groups:

        -  Group 1 participants will receive daily supplements of essential amino acids, which are
           thought to stimulate protein synthesis.

        -  Group 2 participants will receive standard rehabilitation care while in the hospital and
           will serve as controls for the effect of time on recovery.

      Participants will be in the hospital for about 4 days. On the morning of surgery, blood and
      urine collection will occur. During surgery, substances called tracers, measuring the extent
      of protein synthesis and breakdown, will be injected into a vein for the first metabolic
      study. Additional blood and muscle samples will also be taken. After surgery, when
      participants arrive in the surgical recovery unit and are able to eat, they will begin to
      record all food intake and will receive their assigned treatment. Treatment, in the form of
      gel capsules, will be taken 2.5 hours after each meal. Urine will be collected throughout
      hospitalization and blood will be collected each morning. Prior to discharge, a 24-hour
      metabolic study will be performed, including tracer injections and muscle biopsies. After
      discharge, participants will be provided with 6 weeks' worth of their assigned treatment.
      Follow-up visits will occur 2 and ~6 to 8 weeks after surgery. These visits will include
      various muscle function and physical performance tests. Participants will also undergo a dual
      energy x-ray absorptiometry (DEXA) scan, which will be used to determine muscle mass.

      Experiment 2 participants will include individuals scheduled for either hip or knee
      replacement surgery or fracture repair surgery. Participants will be randomly assigned to one
      of two groups:

        -  Group 1 participants will receive the antifungal drug ketoconazole, which is thought to
           reduce levels of the stress hormone cortisol.

        -  Group 2 participants will receive placebo and standard rehabilitation care while in the
           hospital.

      Participants will begin taking their assigned treatments the day prior to surgery; those with
      a hip fracture will take their assigned treatment at least 4 hours prior to surgery. The same
      procedures that occurred in Experiment 1 during surgery and hospitalization will be carried
      out during Experiment 2. The second metabolic study, however, will last only 1 hour and will
      include a standard clinical meal.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle Protein Synthesis</measure>
    <time_frame>Perioperative and discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Maximal Voluntary Contraction</measure>
    <time_frame>Baseline and 6 weeks post surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Hip Fracture</condition>
  <condition>Osteoarthritis</condition>
  <condition>Femur Head Necrosis</condition>
  <arm_group>
    <arm_group_label>Experiment 2 - Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Experiment 1 - Standard of care Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Experiment 1 - Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Experiment 2 - Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Essential amino acid supplement</intervention_name>
    <description>15g of essential amino acid in capsule form three times daily during hospitalization, continued through 6 weeks after discharge.</description>
    <arm_group_label>Experiment 1 - Experimental Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketoconazole</intervention_name>
    <description>200mg ketoconazole twice daily; started night before surgery and continued through hospitalization.</description>
    <arm_group_label>Experiment 2 - Experimental Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo for Ketoconazole</description>
    <arm_group_label>Experiment 2 - Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for All Participants:

          -  Scheduled for surgery because of osteoarthritis, avascular necrosis, fracture, or
             revision of total joint replacement in the hip or knee

        Exclusion Criteria for All Participants:

          -  Taking insulin, thiazolidinediones (TZD), or metformin

          -  Kidney insufficiency, as indicated by serum creatinine of more than 2.0 mg/dl

          -  Recently treated cancer other than basal cell carcinoma

          -  Any other condition or event that would be considered as reason for exclusion by the
             study investigators

          -  Pregnancy

        Exclusion Criteria for Experiment 1 Participants:

          -  Severe hypertension as indicated by requiring more than two drugs for blood pressure
             control

          -  History of hypo- or hypercoagulation disorders, including individuals who have taken
             warfarin (Coumadin)

          -  Atrial fibrillation, angina, or congestive heart failure

        Exclusion Criteria for Experiment 2 Participants:

          -  Liver disease or abnormal liver function tests

          -  HIV infected

          -  Active hepatitis

          -  Any uncontrolled metabolic disease, including liver or kidney disease

          -  Taking medications that use the cytochrome P450 pathway for metabolism and unable to
             discontinue their use for the duration of the study

          -  Require certain medications. More information on this criterion can be found in the
             protocol.

          -  Gastrointestinal absorption disorders that affect nutrient uptake
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arny Ferrando, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2006</study_first_submitted>
  <study_first_submitted_qc>October 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2006</study_first_posted>
  <results_first_submitted>January 6, 2014</results_first_submitted>
  <results_first_submitted_qc>May 30, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 2, 2014</results_first_posted>
  <last_update_submitted>May 30, 2014</last_update_submitted>
  <last_update_submitted_qc>May 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hip Replacement Arthroplasty</keyword>
  <keyword>Hip Replacement Surgery</keyword>
  <keyword>Hip Surgery</keyword>
  <keyword>Hip Rehabilitation</keyword>
  <keyword>Avascular Necrosis</keyword>
  <keyword>Knee replacement surgery</keyword>
  <keyword>Total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Femur Head Necrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketoconazole</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Experiment 1 - Amino Acid Supplement</title>
          <description>Essential amino acid supplement : 15g of essential amino acid in capsule form three times daily during hospitalization, continued through 6 weeks after discharge.</description>
        </group>
        <group group_id="P2">
          <title>Experiment 1 - Standard of Care</title>
          <description>Usual clinical care with no dietary intervention.</description>
        </group>
        <group group_id="P3">
          <title>Experiment 2 - Ketoconazole</title>
          <description>200mg ketoconazole twice daily; started night before surgery and continued through hospitalization.</description>
        </group>
        <group group_id="P4">
          <title>Experiment 2 - Placebo</title>
          <description>Placebo for Ketoconazole twice daily; started night before surgery and continued through hospitalization.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Surgical schedule</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Personal reasons</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Experiment 1 - Amino Acid Supplement</title>
          <description>Essential amino acid supplement : 15g of essential amino acid in capsule form three times daily during hospitalization, continued through 6 weeks after discharge.</description>
        </group>
        <group group_id="B2">
          <title>Experiment 1 - Standard of Care</title>
          <description>Usual clinical care - no dietary intervention.</description>
        </group>
        <group group_id="B3">
          <title>Experiment 2 - Ketoconazole</title>
          <description>200mg ketoconazole twice daily; started night before surgery and continued through hospitalization.</description>
        </group>
        <group group_id="B4">
          <title>Experiment 2 - Placebo</title>
          <description>Placebo for Ketoconazole twice daily; started night before surgery and continued through hospitalization.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="4"/>
            <count group_id="B4" value="8"/>
            <count group_id="B5" value="37"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55" spread="7"/>
                    <measurement group_id="B2" value="56" spread="8"/>
                    <measurement group_id="B3" value="44" spread="15"/>
                    <measurement group_id="B4" value="46" spread="15"/>
                    <measurement group_id="B5" value="51" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Muscle Protein Synthesis</title>
        <time_frame>Perioperative and discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experiment 1 - Amino Acid Supplement</title>
            <description>Essential amino acid supplement : 15g of essential amino acid in capsule form three times daily during hospitalization, continued through 6 weeks after discharge.</description>
          </group>
          <group group_id="O2">
            <title>Experiment 1 - Standard of Care</title>
            <description>Usual clinical care without dietary intervention</description>
          </group>
          <group group_id="O3">
            <title>Experiment 2 - Ketoconazole</title>
            <description>200mg ketoconazole twice daily; started night before surgery and continued through hospitalization.</description>
          </group>
          <group group_id="O4">
            <title>Experiment 2 - Placebo</title>
            <description>Placebo for Ketoconazole twice daily; started night before surgery and continued through hospitalization.</description>
          </group>
        </group_list>
        <measure>
          <title>Muscle Protein Synthesis</title>
          <units>%/d</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="4"/>
                <count group_id="O4" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Perioperative MPS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.38" spread="0.12"/>
                    <measurement group_id="O2" value="0.84" spread="0.11"/>
                    <measurement group_id="O3" value="1.42" spread="0.48"/>
                    <measurement group_id="O4" value="1.36" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discharge MPS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.23" spread="0.16"/>
                    <measurement group_id="O2" value="1.49" spread="0.18"/>
                    <measurement group_id="O3" value="NA">Not performed</measurement>
                    <measurement group_id="O4" value="NA">Not performed</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Maximal Voluntary Contraction</title>
        <time_frame>Baseline and 6 weeks post surgery</time_frame>
        <population>Measure not performed in Experiment 2</population>
        <group_list>
          <group group_id="O1">
            <title>Experiment 1 - Amino Acid Supplement</title>
            <description>Essential amino acid supplement : 15g of essential amino acid in capsule form three times daily during hospitalization, continued through 6 weeks after discharge.</description>
          </group>
          <group group_id="O2">
            <title>Experiment 1 - Standard of Care</title>
            <description>Usual clinical care with no dietary intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Maximal Voluntary Contraction</title>
          <population>Measure not performed in Experiment 2</population>
          <units>kg/kg leg lean mass</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.68" spread="0.3"/>
                    <measurement group_id="O2" value="0.34" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Experiment 1 - Amino Acid Supplement</title>
          <description>Essential amino acid supplement: 15g of essential amino acid in capsule form three times daily during hospitalization, continued through 6 weeks after discharge.</description>
        </group>
        <group group_id="E2">
          <title>Experiment 1 - Standard of Care</title>
          <description>Usual clinical care with no dietary intervention.</description>
        </group>
        <group group_id="E3">
          <title>Experiment 2 - Ketoconazole</title>
          <description>200mg ketoconazole twice daily; started night before surgery and continued through hospitalization.</description>
        </group>
        <group group_id="E4">
          <title>Experiment 2 - Placebo</title>
          <description>Placebo for Ketoconazole twice daily; started night before surgery and continued through hospitalization.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Mastectomy for breast cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Arny Ferrando</name_or_title>
      <organization>UAMS</organization>
      <phone>501-526-5711</phone>
      <email>aferrando@uams.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

